View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Hepatology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 14, 2023
2 min read
Save

Researchers advise limit of 7.4 grams of alcohol per day in early steatotic liver disease

Researchers advise limit of 7.4 grams of alcohol per day in early steatotic liver disease

Researchers recommended that patients with steatotic liver disease who are at a lower risk for advanced cirrhosis should consume no more than 7.4 grams of alcohol per day, the equivalent of a half a 12 oz. beer or half a glass of wine.

SPONSORED CONTENT
December 13, 2023
2 min watch
Save

VIDEO: Interim INTEGRIS-PSC trial results ‘promising’ in primary sclerosing cholangitis

VIDEO: Interim INTEGRIS-PSC trial results ‘promising’ in primary sclerosing cholangitis

BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about interim results from the phase 2a INTEGRIS-PSC trial presented at The Liver Meeting, which showed bexotegrast reduced biomarkers of liver fibrosis vs. placebo.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
December 13, 2023
2 min read
Save

A ‘hidden practice’: Senior physicians see fewer underrepresented patients

A ‘hidden practice’: Senior physicians see fewer underrepresented patients

Senior physicians cared for fewer patients in underrepresented racial and ethnic groups as well as those with Medicaid compared with their junior colleagues within the same practice, a study published in JAMA Network Open found.

SPONSORED CONTENT
December 13, 2023
1 min watch
Save

VIDEO: Preclinical research investigates role of Claudin-1 in cholangiocarcinoma

VIDEO: Preclinical research investigates role of Claudin-1 in cholangiocarcinoma

BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about research assessing the role of Claudin-1 in cholangiocarcinoma, which was presented at The Liver Meeting.

SPONSORED CONTENT
December 13, 2023
2 min read
Save

Liver transplant rates for HCC decline across all races after 2015 MELD policy change

Liver transplant rates for HCC decline across all races after 2015 MELD policy change

Asian patients with hepatocellular carcinoma had the lowest waitlist dropout rates and highest 5-year survival after liver transplantation before and after the policy change, while Black or African American patients had the worst outcomes.

SPONSORED CONTENT
December 13, 2023
3 min watch
Save

VIDEO: ‘Unique’ protocol expands transplant pool to include HCV-infected donors

VIDEO: ‘Unique’ protocol expands transplant pool to include HCV-infected donors

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, spoke with Healio about a presentation from The Liver Meeting on “The Toronto Protocol,” an ultra-short course of glecaprevir/pibrentasvir with ezetimibe.

SPONSORED CONTENT
December 12, 2023
3 min watch
Save

VIDEO: Prevalence of HCV has not changed since 2013-2016 estimate

VIDEO: Prevalence of HCV has not changed since 2013-2016 estimate

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, discusses findings from an abstract at The Liver Meeting, which estimated the prevalence of hepatitis C virus infection in the United States between 2017 and 2020.

SPONSORED CONTENT
December 12, 2023
6 min watch
Save

VIDEO: Treating HCV in pregnancy may reduce risk for mother-to-child transmission

VIDEO: Treating HCV in pregnancy may reduce risk for mother-to-child transmission

BOSTON — Healio spoke with Norah Terrault, MD, MPH, FAASLD, about presentations from The Liver Meeting that investigated testing and treatment of hepatitis C virus infection among pregnant individuals.

SPONSORED CONTENT
December 12, 2023
5 min read
Save

Year-end portfolio checklist: Proactive planning can reduce taxes on investments

Year-end portfolio checklist: Proactive planning can reduce taxes on investments

As we approach the year end, many investors, including physicians, will review their portfolios and assess the last 12 months of performance.

SPONSORED CONTENT
December 11, 2023
2 min read
Save

Point-of-diagnosis HCV treatment model yields 95% SVR at 12 weeks among marginalized group

Point-of-diagnosis HCV treatment model yields 95% SVR at 12 weeks among marginalized group

A test-and-treat model for hepatitis C virus infection among injection drug users and people experiencing homelessness resulted in high levels of treatment initiation, completion and cure, and may expand care access to marginalized groups.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails